69
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Spectroscopic Assessment of Doxorubicin (DOX)-Gemcitabine (GEM) Gold Complex Nanovector as Diagnostic Tool of Galectin-1 Biomarker

, , & ORCID Icon
Pages 95-105 | Received 20 Nov 2023, Accepted 09 Feb 2024, Published online: 29 Mar 2024

References

  • Yang Y, Zheng X, Chen L, et al. Multifunctional gold nanoparticles in cancer diagnosis and treatment. Int J Nanomed. 2022;17:2041–2067. doi:10.2147/IJN.S355142
  • Yang Z, Wang D, Zhang C, et al. The applications of gold nanoparticles in the diagnosis and treatment of gastrointestinal cancer. Front Oncol. 2022;11:819329. doi:10.3389/fonc.2021.819329
  • Singh P, Pandit S, Mokkapati V, Garg A, Ravikumar V, Mijakovic I. Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci. 2018;19:7. doi:10.3390/ijms19071979
  • Medici S, Peana M, Coradduzza D, Zoroddu MA. Gold nanoparticles and cancer: detection, diagnosis and therapy. Semi Cancer Biol. 2021;76:27–37. doi:10.1016/j.semcancer.2021.06.017
  • García Calavia P, Bruce G, Pérez-García L, Russell DA. Photosensitiser-gold nanoparticle conjugates for photodynamic therapy of cancer. Photochem Photobiol Sci. 2018;17(11):1534–1552. doi:10.1039/c8pp00271a
  • Cheng Y, Samia AC, Meyers JD, Panagopoulos I, Fei B, Burda C. highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc. 2008;130(32):10643–10647. doi:10.1021/ja801631c
  • Kashyap BK, Singh VV, Solanki MK, Kumar A, Ruokolainen J, Kesari KK. Smart Nanomaterials in Cancer Theranostics: challenges and Opportunities. ACS Omega. 2023;8(16):14290–14320. doi:10.1021/acsomega.2c07840
  • Seidu TA, Kutoka PT, Asante DO, Farooq MA, Alolga RN, Bo W. Functionalization of nanoparticulate drug delivery systems and its influence in cancer therapy. Pharmaceutics. 2022;14(5):5. doi:10.3390/pharmaceutics14051113
  • Moustaoui H, Movia D, Dupont N, et al. Tunable Design of Gold(III)–Doxorubicin Complex–PEGylated Nanocarrier. The golden doxorubicin for oncological applications. ACS Appl Mater Interfaces. 2016;8(31):19946–19957. doi:10.1021/acsami.6b07250
  • Sahli F, Courcelle M, Palama T, Djaker N, Savarin P, Spadavecchia J. Temozolomide, gemcitabine, and decitabine hybrid nanoconjugates: from design to proof-of-concept (PoC) of synergies toward the understanding of drug impact on human glioblastoma cells. J Med Chem. 2020;63(13):7410–7421. doi:10.1021/acs.jmedchem.0c00694
  • Liu H, Jiang P, Li Z, Li X, Djaker N, Spadavecchia J. HIV-1 tat peptide-gemcitabine gold (III)-PEGylated Complex—Nanoflowers: a Sleek Thermosensitive hybrid nanocarrier as prospective anticancer. Part Part Syst Charact. 2018;35(8):1800082. doi:10.1002/ppsc.201800082
  • Arib C, Spadavecchia J, de la Chapelle ML. Enzyme mediated synthesis of hybrid polyedric gold nanoparticles. Sci Rep. 2021;11(1):3208. doi:10.1038/s41598-021-81751-1
  • Liu Q, Liu H, Sacco P, et al. Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model. Nanoscale Adv. 2022;4(21):4701–4702. doi:10.1039/D2NA90075K
  • Khan M, Boumati S, Arib C, et al. Doxorubicin (DOX) gadolinium-gold-complex: a new way to tune hybrid nanorods as theranostic agent. Int J Nanomed. 2021;16:2219–2236. doi:10.2147/IJN.S295809
  • Liu Q, Sacco P, Marsich E, et al. Lactose-modified chitosan gold(III)-PEGylated complex-bioconjugates: from synthesis to interaction with targeted galectin-1 protein. Bioconjug Chem. 2018;29(10):3352–3361. doi:10.1021/acs.bioconjchem.8b00520
  • Liu Q, Aouidat F, Sacco P, Marsich E, Djaker N, Spadavecchia J. Galectin-1 protein modified gold (III)-PEGylated complex-nanoparticles: proof of concept of alternative probe in colorimetric glucose detection. Colloids Surf B Biointerfaces. 2020;185(110588):15. doi:10.1016/j.colsurfb.2019.110588
  • Mariño KV, Cagnoni AJ, Croci DO, Rabinovich GA. Targeting galectin-driven regulatory circuits in cancer and fibrosis. Nat Rev Drug Discov. 2023;22(4):295–316. doi:10.1038/s41573-023-00636-2
  • Camby I, Le Mercier M, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology. 2006;16(11):13. doi:10.1093/glycob/cwl025
  • Thijssen VLJL, Postel R, Brandwijk RJMGE, et al. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci. 2006;103(43):15975–15980. doi:10.1073/pnas.0603883103
  • Qin H, Qin B, Yuan C, Chen Q, Xing D. Pancreatic Cancer detection via Galectin-1-targeted Thermoacoustic Imaging: validation in an in vivo heterozygosity model. Theranostics. 2020;10(20):9172–9185. doi:10.7150/thno.45994
  • Capasso D, Pirone L, Di Gaetano S, et al. Galectins detection for the diagnosis of chronic diseases: an emerging biosensor approach. TrAC Trend Analytical Chem. 2023;159:116952. doi:10.1016/j.trac.2023.116952
  • Yoshioka K, Sato Y, Murakami T, Tanaka M, Niwa O. One-step detection of galectins on hybrid monolayer surface with protruding lactoside. Anal Chem. 2010;82(4):1175–1178. doi:10.1021/ac9022346
  • van Beijnum JR, Thijssen VL, Läppchen T, et al. A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies. Internat J Can. 2016;139(4):824–835. doi:10.1002/ijc.30131
  • Spadavecchia J, Apchain E, Albéric M, Fontan E, Reiche I. One-step synthesis of collagen hybrid gold nanoparticles and formation on Egyptian-like gold-plated archaeological ivory. Angew Chem Int Ed. 2014;53(32):8363–8366. doi:10.1002/anie.201403567
  • Maurizio C, Flavio R, Maria Enrica DP, Elena T, Giuseppina DL. Conformational features of 4-(N)-squalenoyl-gemcitabine in solution: a combined NMR and molecular dynamics investigation. New J Chem. 2015;39(5):3484–3496. doi:10.1039/C4NJ02091J
  • Johannes L, Wunder C, Shafaq-Zadah M. Glycolipids and lectins in endocytic uptake processes. J Mol Biol. 2016. doi:10.1016/j.jmb.2016.10.027
  • Cousin JM, Cloninger MJ. The role of galectin-1 in cancer progression, and synthetic multivalent systems for the study of galectin-1. Int J Mol Sci. 2016;17(9):1566. doi:10.3390/ijms17091566
  • Marcon P, Marsich E, Vetere A, et al. The role of Galectin-1 in the interaction between chondrocytes and a lactose-modified chitosan. Biomaterials. 2005;26(24):4975–4984. doi:10.1016/j.biomaterials.2005.01.044
  • Rwere F, Mak PJ, Kincaid JR. Resonance Raman interrogation of the consequences of heme rotational disorder in myoglobin and its ligated derivatives. Biochemistry. 2008;47(48):12869–12877. doi:10.1021/bi801779d
  • Liu J, Peng Q. Protein-gold nanoparticle interactions and their possible impact on biomedical applications. Acta Biomater. 2017;55:13–27. doi:10.1016/j.actbio.2017.03.055
  • Pace CN, Fu H, Fryar KL, et al. Contribution of hydrophobic interactions to protein stability. J Mol Biol. 2011;408(3):514–528. doi:10.1016/j.jmb.2011.02.053